These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38560631)
21. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. Nolan SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001769. PubMed ID: 27123830 [TBL] [Abstract][Full Text] [Related]
22. CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation. Twardowschy CA; Werneck LC; Scola RH; De Paola L; Silvado CE Arq Neuropsiquiatr; 2011 Apr; 69(2A):153-8. PubMed ID: 21537551 [TBL] [Abstract][Full Text] [Related]
23. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. Nolan SJ; Marson AG; Pulman J; Tudur Smith C Cochrane Database Syst Rev; 2013 Aug; (8):CD001769. PubMed ID: 23970302 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications. Shaikh AS; Guo R Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004 [TBL] [Abstract][Full Text] [Related]
25. Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacin. Pollak PT; Slayter KL Ann Pharmacother; 1997 Jan; 31(1):61-4. PubMed ID: 8997469 [TBL] [Abstract][Full Text] [Related]
26. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Chang WC; Hung SI; Carleton BC; Chung WH Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):723-734. PubMed ID: 32510242 [TBL] [Abstract][Full Text] [Related]
27. Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2019 Jul; 7(7):CD002217. PubMed ID: 31425629 [TBL] [Abstract][Full Text] [Related]
28. Potentially Unsafe Herb-drug Interactions Between a Commercial Product of Noni Juice and Phenytoin- A Case Report. Kang YC; Chen MH; Lai SL Acta Neurol Taiwan; 2015 Jun; 24(2):43-6. PubMed ID: 26179835 [TBL] [Abstract][Full Text] [Related]
29. Paradoxical Seizure Response to Phenytoin in an Epileptic Heroin Addict. Vasagar B; Verma BR; Dewberry RG; Pula T Neurologist; 2015 Jun; 19(6):158-9. PubMed ID: 26075470 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological treatments for preventing epilepsy following traumatic head injury. Thompson K; Pohlmann-Eden B; Campbell LA; Abel H Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009900. PubMed ID: 26259048 [TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in rats. Kumar R; Arora R; Sarangi SC; Ganeshan N S; Agarwal A; Kaleekal T; Gupta YK J Ethnopharmacol; 2021 Apr; 270():113784. PubMed ID: 33429032 [TBL] [Abstract][Full Text] [Related]
32. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ; JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Reeta KH; Mehla J; Pahuja M; Gupta YK Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922 [TBL] [Abstract][Full Text] [Related]
36. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy. Chaudhary N; Kabra M; Gulati S; Gupta YK; Pandey RM; Bhatia BD BMC Pediatr; 2016 May; 16():66. PubMed ID: 27179628 [TBL] [Abstract][Full Text] [Related]
37. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicity. Depondt C; Godard P; Espel RS; Da Cruz AL; Lienard P; Pandolfo M Eur J Neurol; 2011 Sep; 18(9):1159-64. PubMed ID: 21338443 [TBL] [Abstract][Full Text] [Related]
38. Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms. Hung CC; Lin CJ; Chen CC; Chang CJ; Liou HH Ther Drug Monit; 2004 Oct; 26(5):534-40. PubMed ID: 15385837 [TBL] [Abstract][Full Text] [Related]
39. A Phenytoin-Induced Ataxia Mimicking a Stroke. Urushidani S Am J Emerg Med; 2022 Oct; 60():226.e5-226.e6. PubMed ID: 35863977 [TBL] [Abstract][Full Text] [Related]
40. Phenytoin-Induced Paradoxical Seizures and Blood Dyscrasias in a Patient Receiving Rapid Intravenous Infusion: A Case Report. Sudarsan P; Varghese R; Suresh A; Radhakrishnan A J Pharm Pract; 2021 Apr; 34(2):306-308. PubMed ID: 31875759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]